Enter your search terms:
Top

Uncategorized

MonoSol Rx Aligns Executive Leadership to Maximize Growth Opportunities, Operational Excellence and R&D Pipeline

Mark Schobel, CEO, Assumes Added Role of Chief Technology Officer; Keith Kendall, CFO, Named Chief Operating Officer Schobel and Kendall to Serve as Co-Presidents Warren, NJ (June 23, 2011) – MonoSol Rx, the developers of PharmFilm® technology and a drug delivery company specializing in proprietary pharmaceutical film products, announced today...

MonoSol Rx Announces Reckitt Benckiser FDA Approval of Suboxone Sublingual Film for Treatment of Opioid Dependence

Second FDA-Approval Drug Based on MonoSol Rx's PharmFilm® Technology; First Sublingually-Administered Prescription Film Product Warren, NJ (August 31, 2010) – MonoSol Rx, the developers of PharmFilm® technology and a drug delivery company specializing in film pharmaceutical products, today announced that its partner, Reckitt Benckiser Pharmaceuticals Inc., a wholly-owned subsidiary of...

MonoSol Rx Announces FDA Approval of ZuplenzB. Oral Soluble Film for Treatment of Nausea and Vomiting

First NDA Approval Based on PharmFilm® Technology First FDA Approval for a Prescription Oral Soluble Film for Prevention of Chemotherapy-induced, Radiotherapy-induced, and Postoperative Nausea and Vomiting Warren, NJ, and Balerna, Switzerland (July 7, 2010) – MonoSol Rx, the developers of PharmFilm® technology and a drug delivery company specializing in film pharmaceutical...

MonoSol Rx Appoints Dr. Mary Ellen Norvitch Vice President of Regulatory Affairs, Clinical Affairs and Quality Assurance

Industry Veteran to Support Rapidly Advancing Pipeline Warren, NJ (June 17, 2010) – MonoSol Rx, the developer of PharmFilm® drug delivery technology, today announced the appointment of Mary Ellen Norvitch, Ph.D. to the newly created position of Vice President, Regulatory Affairs/Clinical Affairs/Quality Assurance.  Effective immediately, Dr. Norvitch will...